References
- MatsumuraYMaedaHA new concept for macromolecular therapeutics in cancer chemotherapy: Mechanism of tumoritropic accumulation of proteins and the antitumor agent smancsCancer Res198646638763922946403
- GreishKFangJInutsukaTMacromolecular therapeutics: Advantages and prospects with special emphasis on solid tumour targetingClin Pharmacokinet2003421089110514531722
- ChipmanSDOldhamFBPezzoniGBiological and clinical characterization of paclitaxel poliglumex (PPX, CT-2103), a macromolecular polymer-drug conjugateInt J Nanomedicine2006137538317722272
- SingerJWBakerBde VriesPPoly-(L)-glutamic acid-paclitaxel (CT-2103) [XYOTAX], a biodegradable polymeric drug conjugate: Characterization, preclinical pharmacology, and preliminary clinical dataAdv Exp Med Biol2003519819912675210
- MilasLMasonKAHunterNPoly(L-glutamic acid)-paclitaxel conjugate is a potent enhancer of tumor radiocurabilityInt J Radiat Oncol Biol Phys20035570771212573758
- SingerJWShafferSBakerBPaclitaxel poliglumex (XYOTAX; CT-2103): An intracellularly targeted taxaneAnticancer Drugs2005624325415711176
- SingerJWPaclitaxel poliglumex (XYOTAX, CT-2103): A macromolecular taxaneJ Control Release200510912012616297482
- LangerCJCT-2103. A novel macromolecular taxane with potential advantages compared with conventional taxanesClin Lung Cancer20046 Suppl 2S85S8815638965
- BoddyAVPlummerERToddRA phase I and pharmacokinetic study of paclitaxel poliglumex (XYOTAX), investigating both 3-weekly and 2-weekly schedulesClin Cancer Res2005117834784016278406
- SabbatiniPAghajanianCDizonDPhase II study of CT-2103 in patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal carcinomaJ Clin Oncol2004224523453115542803
- NemunaitisJCunninghamCSenzerNPhase I study of CT-2103, a polymer-conjugated paclitaxel, and carboplatin in patients with advanced solid tumorsCancer Invest20052367167616377585
- AdlerBKUnfractionated heparin and other antithrombin mediated anticoagulantsClin Lab Sci20041711311715168893
- BransonHESlaterLMAndersonMGProthrombin time after heparin removal. Application to monitoring simultaneous anticoagulation with heparin and coumarinsAm J Clin Pathol197971665667453082
- BeutlerELichtmanMACollerBSWilliams Hematology5th edNew York NYMcGraw-Hill1995